POLE and Lynch syndrome: In our study, 8 patients were identified with pathogenic or likely pathogenic germline mutations in non-Lynch syndrome genes (MUTYH, GALNT 12, POLE, MPL, ATM, and ERCC4), which indicated that there may be other genes outside of Lynch syndrome associated with endometrial cancer.